Last update 01 Nov 2024

BI-9321

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
NSD3
Mechanism
NSD3 antagonists(nuclear receptor binding SET domain protein 3 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
Active Organization
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC22H21FN4
InChIKeyWOAOENGFAAUUGT-UHFFFAOYSA-N
CAS Registry2387510-86-1

Related

100 Clinical Results associated with BI-9321
Login to view more data
100 Translational Medicine associated with BI-9321
Login to view more data
100 Patents (Medical) associated with BI-9321
Login to view more data
100 Deals associated with BI-9321
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
AT
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
08 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free